Literature DB >> 21793793

Working memory and multidimensional schizotypy: dissociable influences of the different dimensions.

Mia Schmidt-Hansen1, R C Honey.   

Abstract

Compromised working memory is considered a core deficit of schizophrenia and a potential endophenotype for the liability to develop schizophrenia. In keeping with this suggestion, working memory has also been found to be disrupted in people with high levels of schizotypy. However, it is unclear whether this disruption is linked to positive, negative, or disorganized symptoms/characteristics. This issue is the focus of the present investigation. The relationship between multidimensional schizotypy and working memory performance was investigated in 289 participants. Working memory was measured using an n-back task with three conditions; 0-back, 1-back, and 2-back. Covarying for the effect of shared variance between the schizotypy dimensions, we found reduced working memory performance in participants who displayed high levels of positive schizotypy and, to some extent, in participants with low levels of negative schizotypy. The results are discussed in terms of Baddeley's (1986) model of working memory and potential underlying neurological mechanisms.

Entities:  

Mesh:

Year:  2009        PMID: 21793793     DOI: 10.1080/02643291003644501

Source DB:  PubMed          Journal:  Cogn Neuropsychol        ISSN: 0264-3294            Impact factor:   2.468


  13 in total

1.  Neuropsychological effects associated with recreational cocaine use.

Authors:  Kirstie Soar; Colette Mason; Anita Potton; Lynne Dawkins
Journal:  Psychopharmacology (Berl)       Date:  2012-02-29       Impact factor: 4.530

Review 2.  Cognition and brain function in schizotypy: a selective review.

Authors:  Ulrich Ettinger; Christine Mohr; Diane C Gooding; Alex S Cohen; Alexander Rapp; Corinna Haenschel; Sohee Park
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

3.  Association of Schizotypy With Dimensions of Cognitive Control: A Meta-Analysis.

Authors:  Maria Steffens; Inga Meyhöfer; Kaja Fassbender; Ulrich Ettinger; Joseph Kambeitz
Journal:  Schizophr Bull       Date:  2018-10-15       Impact factor: 9.306

4.  Individual differences in the executive control of attention, memory, and thought, and their associations with schizotypy.

Authors:  Michael J Kane; Matt E Meier; Bridget A Smeekens; Georgina M Gross; Charlotte A Chun; Paul J Silvia; Thomas R Kwapil
Journal:  J Exp Psychol Gen       Date:  2016-06-16

Review 5.  Schizotypal personality disorder: a current review.

Authors:  Daniel R Rosell; Shira E Futterman; Antonia McMaster; Larry J Siever
Journal:  Curr Psychiatry Rep       Date:  2014-07       Impact factor: 5.285

6.  Shift toward prior knowledge confers a perceptual advantage in early psychosis and psychosis-prone healthy individuals.

Authors:  Christoph Teufel; Naresh Subramaniam; Veronika Dobler; Jesus Perez; Johanna Finnemann; Puja R Mehta; Ian M Goodyer; Paul C Fletcher
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-12       Impact factor: 11.205

Review 7.  Linking RDoC and HiTOP: A new interface for advancing psychiatric nosology and neuroscience.

Authors:  Giorgia Michelini; Isabella M Palumbo; Colin G DeYoung; Robert D Latzman; Roman Kotov
Journal:  Clin Psychol Rev       Date:  2021-03-24

8.  Impairments of working memory in schizophrenia and bipolar disorder: the effect of history of psychotic symptoms and different aspects of cognitive task demands.

Authors:  Dorota Frydecka; Abeer M Eissa; Doaa H Hewedi; Manal Ali; Jarosław Drapała; Błażej Misiak; Ewa Kłosińska; Joseph R Phillips; Ahmed A Moustafa
Journal:  Front Behav Neurosci       Date:  2014-11-28       Impact factor: 3.558

9.  WORKING MEMORY IMPAIRMENT AS AN ENDOPHENOTYPIC MARKER OF A SCHIZOPHRENIA DIATHESIS.

Authors:  Sohee Park; Diane C Gooding
Journal:  Schizophr Res Cogn       Date:  2014-09-01

10.  Working memory capacity and psychotic-like experiences in a general population sample of adolescents and young adults.

Authors:  Tim B Ziermans
Journal:  Front Psychiatry       Date:  2013-12-03       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.